These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival. Ramirez AE, Cheng HY, Lao WW, Wang YL, Wen CJ, Wallace CG, Lin CF, Shih LY, Chuang SH, Wei FC. Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714 [Abstract] [Full Text] [Related]
9. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation. Radu CA, Fischer S, Diehm Y, Hetzel O, Neubrech F, Dittmar L, Kleist C, Gebhard MM, Terness P, Kneser U, Kiefer J. Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033 [Abstract] [Full Text] [Related]
10. A local drug delivery system prolongs graft survival by dampening T cell infiltration and neutrophil extracellular trap formation in vascularized composite allografts. Arenas Hoyos I, Helmer A, Yerly A, Lese I, Hirsiger S, Zhang L, Casoni D, Garcia L, Petrucci M, Hammer SE, Duckova T, Banz Y, Montani M, Constantinescu M, Vögelin E, Bordon G, Aleandri S, Prost JC, Taddeo A, Luciani P, Rieben R, Sorvillo N, Olariu R. Front Immunol; 2024 Feb; 15():1387945. PubMed ID: 38887281 [Abstract] [Full Text] [Related]
13. Targeting the Kv1.3 potassium channel for immunosuppression in vascularized composite allotransplantation - a pilot study. Hautz T, Krapf C, Grahammer J, Zelger B, Hickethier T, Seger C, Eberhart N, Wallner C, Messner F, Kotsch K, Griesmacher A, Brandacher G, Lee WP, Margreiter R, Pratschke J, Glossmann H, Schneeberger S. Transpl Int; 2013 May; 26(5):552-61. PubMed ID: 23489391 [Abstract] [Full Text] [Related]
14. Pharmacokinetics and Biodistribution of Tacrolimus after Topical Administration: Implications for Vascularized Composite Allotransplantation. Feturi FG, Schnider JT, Fanzio PM, Erbas VE, Oksuz S, Sahin H, Dong L, Unadkat JM, Spiess AM, Plock JA, Solari MG, Gorantla VS, Venkataramanan R. Pharm Res; 2020 Oct 16; 37(11):222. PubMed ID: 33067715 [Abstract] [Full Text] [Related]
15. Efficacy of single-agent immunosuppressive regimens in a murine model of vascularized composite allotransplantation. Guo Y, Messner F, Etra JW, Beck SE, Kalsi R, Furtmüller GJ, Schneeberger S, Chol Oh B, Brandacher G. Transpl Int; 2020 Aug 16; 33(8):948-957. PubMed ID: 32299127 [Abstract] [Full Text] [Related]
16. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation. Plock JA, Schnider JT, Schweizer R, Zhang W, Tsuji W, Waldner M, Solari MG, Marra KG, Rubin JP, Gorantla VS. Transplantation; 2017 Jan 16; 101(1):e1-e11. PubMed ID: 27893612 [Abstract] [Full Text] [Related]
17. Tacrolimus-Eluting Disk within the Allograft Enables Vascularized Composite Allograft Survival with Site-Specific Immunosuppression without Systemic Toxicity. Feturi FG, Unadkat JV, Zhang W, Hag ME, Wang Y, Komatsu C, Grybowski D, Zhang Z, Erbas V, Sahin H, Mcclaine S, Oksuz S, Plock J, Gorantla VS, Washington KM, Solari MG, Venkataramanan R, Spiess AM. Pharm Res; 2022 Sep 16; 39(9):2179-2190. PubMed ID: 35915321 [Abstract] [Full Text] [Related]
19. Local Delivery of Adipose Stem Cells Promotes Allograft Survival in a Rat Hind-Limb Model of Vascularized Composite Allotransplantation. Zhang W, Lee PL, Li J, Komatsu C, Wang Y, Sun H, DeSanto M, Washington K, Gorantla V, Kokai L, Solari MG. Plast Reconstr Surg; 2024 Jan 01; 153(1):79e-90e. PubMed ID: 37014960 [Abstract] [Full Text] [Related]